131 related articles for article (PubMed ID: 22580644)
1. Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population.
Liu Y; Chen H; Chen L; Hu C
Hepatogastroenterology; 2012 Jun; 59(116):977-80. PubMed ID: 22580644
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
[TBL] [Abstract][Full Text] [Related]
3. An association of polymorphism of DNA repair genes XRCC1 and XRCC3 with colorectal cancer.
Krupa R; Blasiak J
J Exp Clin Cancer Res; 2004 Jun; 23(2):285-94. PubMed ID: 15354414
[TBL] [Abstract][Full Text] [Related]
4. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.
Liang J; Jiang T; Yao RY; Liu ZM; Lv HY; Qi WW
Cancer Chemother Pharmacol; 2010 Aug; 66(3):493-500. PubMed ID: 19960344
[TBL] [Abstract][Full Text] [Related]
5. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
[TBL] [Abstract][Full Text] [Related]
6. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.
Gan Y; Li XR; Chen DJ; Wu JH
Asian Pac J Cancer Prev; 2012; 13(11):5721-4. PubMed ID: 23317245
[TBL] [Abstract][Full Text] [Related]
8. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
Stern MC; Siegmund KD; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):609-15. PubMed ID: 15767338
[TBL] [Abstract][Full Text] [Related]
9. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.
Park DJ; Stoehlmacher J; Zhang W; Tsao-Wei DD; Groshen S; Lenz HJ
Cancer Res; 2001 Dec; 61(24):8654-8. PubMed ID: 11751380
[TBL] [Abstract][Full Text] [Related]
10. MS-920: DNA repair gene polymorphisms, diet and colorectal cancer risk in Taiwan.
Yeh CC; Hsieh LL; Tang R; Chang-Chieh CR; Sung FC
Cancer Lett; 2005 Jun; 224(2):279-88. PubMed ID: 15914278
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Huang ZH; Hua D; Du X
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
Ryk C; Kumar R; Thirumaran RK; Hou SM
Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer.
Stoehlmacher J; Ghaderi V; Iobal S; Groshen S; Tsao-Wei D; Park D; Lenz HJ
Anticancer Res; 2001; 21(4B):3075-9. PubMed ID: 11712813
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population.
Shen H; Wang X; Hu Z; Zhang Z; Xu Y; Hu X; Guo J; Wei Q
Cancer Lett; 2004 Mar; 206(1):51-8. PubMed ID: 15019159
[TBL] [Abstract][Full Text] [Related]
15. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract][Full Text] [Related]
16. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients.
Gal TJ; Huang WY; Chen C; Hayes RB; Schwartz SM
Laryngoscope; 2005 Dec; 115(12):2221-31. PubMed ID: 16369171
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.
Ye F; Liu Z; Tan A; Liao M; Mo Z; Yang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):733-40. PubMed ID: 23299794
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer.
Martinez-Balibrea E; Abad A; Aranda E; Sastre J; Manzano JL; Díaz-Rubio E; Gómez-España A; Aparicio J; García T; Maestu I; Martínez-Cardús A; Ginés A; Guino E;
Eur J Cancer; 2008 Jun; 44(9):1229-37. PubMed ID: 18448328
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy.
Ruzzo A; Graziano F; Loupakis F; Rulli E; Canestrari E; Santini D; Catalano V; Ficarelli R; Maltese P; Bisonni R; Masi G; Schiavon G; Giordani P; Giustini L; Falcone A; Tonini G; Silva R; Mattioli R; Floriani I; Magnani M
J Clin Oncol; 2007 Apr; 25(10):1247-54. PubMed ID: 17401013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
